PenderFund Capital Management’s Elevation Oncology ELEV Stock Holding History

PenderFund Capital Management’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-195,700	Closed	-$71.8K	–	217
2025 Q2	$71.8K	Buy	+195,700	New	+$65.3K	0.02%	119

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

PenderFund Capital Management's ELEV Position: Q3 2025 in Review

PenderFund Capital Management sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 195,700 shares — an estimated $71.8K sold.

PenderFund Capital Management first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $71.8K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

PenderFund Capital Management reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
PenderFund Capital Management sold 195,700 Elevation Oncology shares in Q3 2025, an estimated $71.8K.
PenderFund Capital Management first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
PenderFund Capital Management's Elevation Oncology position peaked at $71.8K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on PenderFund Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.